Assessing Coughing and Wheezing in Lung Cancer: A Pilot Study

Cynthia Chernecky

Linda Sarna

Jennifer L. Waller

Mary-Lynn Becht

ONF 2004, 31(6), 1095-1101. DOI: 10.1188/04.ONF.1095-1101

Purpose/Objectives: To establish reliability and validity of two self-report questionnaires, the Lung Cancer Cough Questionnaire and the Lung Cancer Wheezing Questionnaire.

Jump to a section


    Beckles, M.A., Spiro, S.G., Colice, G.L., & Rudd, R.M. (2003). Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest, 123(Suppl. 1), 97S-105S.

    Bergner, M., Bobbitt, R.A., Pollard, W.E., Martin, D.P., & Gilson, B.S. (1976). The sickness impact profile: Validation of a health status measure. Medical Care, 14, 57-67.

    Burns, N., & Groves, S.K. (1999). Understanding nursing research. Philadelphia: W.B. Saunders.

    Carney, I., Gibson, P.G., Murree-Allen, K., Saltos, N., Olson, L.G., & Hensley, M.J. (1997). A systematic evaluation of mechanisms in chronic cough. American Journal of Respiratory and Critical Care Medicine, 156, 211-216.

    Cella, D., Eton, D.T., Fairclough, D.L., Bonomi, P., Heyes, A.E., Silberman, C., et al. (2002). What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. Journal of Clinical Epidemiology, 55, 285-295.

    Chang, J.A., Curtis, J.R., Patrick, D.L., & Raghu, G. (1999). Assessment of health-related quality of life in patients with interstitial lung disease. Chest, 116, 1175-1190.

    Chernecky, C., & Sarna, L. (2000). Pulmonary toxicities of cancer therapy. Critical Care Nursing Clinics of North America, 12, 281-295.

    Cooley, M.E. (2000). Symptoms in adults with lung cancer: A systematic research review. Journal of Pain and Symptom Management, 19, 137-153.

    Drings, P. (1999). Dyspnea in cancer patients. Supportive Care in Cancer, 7, 215-216.

    Dudgeon, D.J., & Rosenthal, S. (1996). Management of dyspnea and cough in patients with cancer. Hematology/Oncology Clinics of North America, 10, 157-171.

    Epstein, S.K., Faling, L.J., Daly, B.D., & Celli, B.R. (1993). Predicting complications after pulmonary resection: Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest, 104, 694-700.

    Escalante, C.P., Martin, C.G., Elting, L.S., Cantor, S.B., Harle, T.S., Price, K.J., et al. (1996). Dyspnea in cancer patients. Cancer, 78, 1314-1319.

    Evans, W.K., Kocha, W., Gagliardi, A., Eady, A., & Newman, T.E. (1999). The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Support Group. Cancer Prevention and Control, 3, 84-94.

    Fayers, P., Bottomley, A., EORTC Quality of Life Group, & Quality of Life Unit. (2002). Quality of life research within the EORTC—The EORTC QLQ-C30. European Journal of Cancer, 38(Suppl. 4), S125-S133.

    Ferguson, G., Enright, P., Buist, A., & Higgins, M. (2000). Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education program. Respiratory Care, 45, 513-530.

    French, C., Irwin, R., Curley, F., & Krikorian, C. (1998). Impact of chronic cough on quality of life. Archives of Internal Medicine, 158, 1657-1661.

    Gift, A.G., & Narsavage, G. (1998). Validity of the numeric rating scale as a measure of dyspnea. American Journal of Critical Care, 7, 200-204.

    Gridelli, C., Perrone, F., Nelli, F., Ramponi, S., & De Marinis, F. (2001). Quality of life in lung cancer patients. Annals of Oncology, 12(Suppl. 3), S21-S25.

    Guyatt, G.H., Townsend, M., Berman, L.B., & Pugsley, S.O. (1987). Quality-of-life in patients with chronic airflow limitation. British Journal of Diseases of the Chest, 81, 45-54.

    Hajiro, T., Nishimura, K., Tsukino, M., Ikeda, A., Koyama, H., & Izumi, T. (1998). Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 158, 1185-1189.

    Hatipoglu, U., Laghi, F., Cattapan, S.E., & Chandrasekhar, A.J. (2002). Unilateral expiratory airflow obstruction during forced exhalation. Respiratory Care, 47, 693-695.

    Herth, F., Ernst, A., & Becker, H.D. (2001). Long-term outcome in patients with hemoptysis of unknown origin. Chest, 120, 1592-1594.

    Hollen, P.J., Gralla, R.J., Kris, M.G., Eberly, S.W., & Cox, C. (1999). Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Supportive Care in Cancer, 7, 140-148.

    Hunt, S.M., McEwen, J., & McKenna, S.P. (1986). Measuring health status. London: Croom Helm.

    Irwin, R.S., Boulet, L.P., Cloutier, M.M., Fuller, R., Gold, P.M., Hoffstein, V., et al. (1998). Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest, 114(2, Suppl. Managing), 133S-181S.

    Irwin, R.S., & Madison, J.M. (2000). The diagnosis and treatment of cough. New England Journal of Medicine, 343, 1715-1721.

    Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., et al. (2004). Cancer statistics, 2004. CA: A Cancer Journal for Clinicians, 54, 8-29.

    Jones, P.W., Quirk, F.H., Baveystock, C.M., & Littlejohns, P. (1992). A self-complete measure of chronic airflow limitation—The St. George's Respiratory Questionnaire. American Review of Respiratory Disease, 145, 1321-1327.

    Kuo, C.W., Chen, Y.M., Chao, J.Y., Tsai, C.M., & Perng, R.P. (2000). Non-small cell lung cancer in very young and very old patients. Chest, 117, 354-357.

    Laforga, J.B. (1999). Giant cell carcinoma of the lung. Report of a case with cytohistologic and clinical correlation. Acta Cytologica, 43, 263-267.

    Landis, S.H., Murray, T., Bolden, S., & Wingo, P.A. (1998). Cancer statistics, 1998. CA: A Cancer Journal for Clinicians, 48, 6-29.

    Langendijk, J.A., ten Velde, G.P., Aaronson, N.K., de Jong, J.M., Muller, M.J., & Wouters, E.F. (2000). Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study. International Journal of Radiation Oncology, Biology, Physics, 47, 149-155.

    Larson, K.R., Svendsen, U.G., Milman, N., Brenoe, J., & Peterson, B.N. (1997). Cardiopulmonary function at rest and during exercise after resection for bronchial carcinoma. Annals of Thoracic Surgery, 64, 960-964.

    Lee, K.S., Kim, Y., Han, J., Ko, E.J., Park, C.K., & Primack, S.L. (1997). Bronchioloaveolar carcinoma: Clinical, histopathologic, and radiologic findings. Radiographics, 17, 1345-1357.

    Liedekerken, B.M., Hoogendam, A., Buntinx, F., van der Weyden, T., & de Vet, H.C. (1997). Prolonged coughing and lung cancer: The need for more general practice research to inform clinical decision-making. British Journal of General Practice, 47, 505.

    Linder, J.A., & Stafford, R.S. (2001). The diagnosis and treatment of cough [Letter to the editor]. New England Journal of Medicine, 344, 1097.

    Lubbe, A.S., Krischke, N.R., Dimeo, F., Forkel, S., & Petermann, F. (2001). Health-related quality of life and pulmonary function in lung cancer patients undergoing medical rehabilitation treatment. Wiener Medizinische Wochenschrift (Germany), 151, 29-34.

    Mahler, D.A., Faryniarz, K., Tomlinson, D., Colice, G.L., Robins, A.G., Olmstead, E.M., et al. (1992). Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest, 102, 395-401.

    Mahler, D.A., & Jones, P.W. (1997). Measurement of dyspnea and quality of life in advanced lung disease. Clinics in Chest Medicine, 18, 457-469.

    Mahler, D.A., Weinberg, D.H., Wells, C.K., & Feinstein, A.R. (1984). The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two clinical indexes. Chest, 85, 751-758.

    Martins, S.J., & Pereira, J.R. (1999). Clinical factors and prognosis in non-small cell lung cancer. American Journal of Clinical Oncology, 22, 453-457.

    Mehdi, S.A., Etzell, J.E., Newman, N.B., Weidner, N., Kohman, L.J., & Graziano, S.L. (1998). Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and stage II non-small-cell lung cancer. Lung Cancer, 20, 99-108.

    Mercandante, S., Casuccio, A., & Fulfaro, F. (2000). The course of symptom frequency and intensity in advanced cancer patients followed at home. Journal of Pain and Symptom Management, 20, 104-112.

    Moroni, M., Porta, C., Gualtieri, G., Nastasi, G., & Tinelli, C. (1996). Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients. British Journal of Cancer, 74, 309-311.

    Muers, M.F., & Round, C.E. (1993). Palliation of symptoms in non-small cell lung cancer: A study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax, 48, 339-343.

    Nurses develop treatment for breathlessness. (1999). Journal of Advanced Nursing, 30, 281-282.

    O'Driscoll, M., Corner, J., & Bailey, C. (1999). The experience of breathlessness in lung cancer. European Journal of Cancer Care, 8, 37-43.

    Ripamonti, C. (1999). Management of dyspnea in advanced cancer patients. Supportive Care in Cancer, 7, 233-243.

    Ripamonti, C., & Bruera, E. (1997). Dyspnea: Pathophysiology and assessment. Journal of Pain and Symptom Management, 13, 220-232.

    Roszkowski, K., Pluzanska, A., Krzakowski, M., Smith, A.P., Saigi, E., Aasebo, U., et al. (2000). A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer, 27, 145-157.

    Sarna, L. (1993). Correlates of symptom distress in women with lung cancer. Cancer Practice, 17, 21-28.

    Sarna, L. (1994). Functional status in women with lung cancer. Cancer Nursing, 17, 87-93.

    Sarna, L. (1998). Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer. Oncology Nursing Forum, 25, 1041-1048.

    Sarna, L., Lindsey, A.M., Dean, H., Brecht, M.L., & McCorkle, R. (1993). Nutritional intake, weight change, symptom distress, functional status over time in adults with lung cancer. Oncology Nursing Forum, 20, 481-489.

    Sarna, L., Padilla, G., Holmes, C., Tashkin, D., Brecht, M.L., & Evangelista, L. (2002). Quality of life of long-term survivors of non-small-cell lung cancer. Journal of Clinical Oncology, 20, 2920-2929.

    Scieszka, M., Zielinski, M., Machalski, M., & Herman, Z.S. (2000). Quality of life in cancer patients treated with chemotherapy. Neoplasma, 47, 396-399.

    Scully, R.E., Mark, E.J., McNeely, W.F., Ebeling, S.H., & Philips, L.D. (1997). Clinicopathological exercises: Case 20-1997: A 74-year-old man with progressive cough, dyspnea, and pleural thickening. New England Journal of Medicine, 336, 1895-1903.

    Selim, A.J., Ren, X.S., Fincke, G., Rogers, W., Lee, A., & Kazis, L. (1997). A symptom-based measure of the severity of chronic lung disease: Results from the Veterans Health Study. Chest, 111, 1607-1614.

    Sibley, G.S., Jamieson, T.A., Marks, L.B., Anscher, M.S., & Prosnitz, L.R. (1998). Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. International Journal of Radiation Oncology, Biology, Physics, 40, 149-154.

    Sprangers, M.A., Cull, A., Groenvold, M., Bjordal, K., Blazeby, J., & Aaronson, N.K. (1998). The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview. Quality of Life Research, 7, 291-300.

    Stephens, R.J., Hopwood, P., & Girling, D.J. (1999). Defining and analyzing symptom palliation in cancer clinical trials: A deceptively difficult exercise. British Journal of Cancer, 79, 538-544.

    Tanaka, K., Akechi, T., Okuyama, T., Nishiwaki, Y., & Uchitomi, Y. (2000). Development and validation of the Cancer Dyspnea Scale: A multidimensional, brief, self-rating scale. British Journal of Cancer, 82, 800-805.

    Thomas, J.R., & Von Gunten, C.F. (2002). Treatment of dyspnea in cancer patients. Oncology, 16, 745-750.

    Tyczynski, J.E., Bray, F., & Parkin, D.M. (2003). Lung cancer in Europe in 2000: Epidemiology, prevention, and early detection. Lancet Oncology, 4, 45-55.

    Vaaler, A.K., Forrester, J.M., Lesar, M., Edison, M., Venzon, D., & Johnson, B.E. (1997). Obstructive atelectasis in patients with small cell lung cancer. Incidence and response to treatment. Chest, 111, 115-120.

    Vyas, R.K., Suryanarayana, U., Dixit, S., Singhal, S., Bhavsar, D.C., Neema, J.P., et al. (1998). Inoperable non-small cell lung cancer: Palliative radiotherapy and two weekly fractions. Indian Journal of Chest Disease and Allied Sciences, 40, 171-174.

    Waltz, C.F., Strickland, O.L., & Lenz, E.R. (1991). Measurement in nursing research. Philadelphia: FA Davis.

    Ware, J.E., Jr., & Sherbourne, C.D. (1992). The MOS short-form health survey (SF-36): Conceptual framework and item selection. Medical Care, 30, 473-483.

    White, S.C., Cheeseman, S., Thatcher, N., Anderson, H., Carrington, B., Hearn, S., et al. (2000). Phase II study of oral topotecan in advanced nonsmall cell lung cancer. Clinical Cancer Research, 6, 868-873.

    Wijkstra, P.J., Ten Vergert, E.M., Van Altena, R., Otten, V., Postma, D.S., Kraan, J., et al. (1994). Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax, 49, 465-467.